Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
Saved in:
Main Authors: | Mustafa Erman, Bivas Biswas, Pongwut Danchaivijitr, Lingwu Chen, Yoke Fui Wong, Tarek Hashem, Chun Sen Lim, Bulent Karabulut, Hsiao-Jen Chung, Chandrasekhar Chikatapu, Sara Ingles, Khemaies Slimane, Ravindran Kanesvaran |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c4088abcfc2b4a2295bba6b69afcf827 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pazopanib for the treatment of soft-tissue sarcoma
by: Heudel P, et al.
Published: (2012) -
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
by: Peter E Clark
Published: (2010) -
Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue Sarcoma
by: Laura Molenaar-Kuijsten, et al.
Published: (2021) -
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
by: Sewanti Limaye, et al.
Published: (2021) -
Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis.
by: Hisaki Aiba, et al.
Published: (2021)